Amag Pharmaceuticals (NASDAQ:AMAG)’s share price soared 2.85% or 0.4 to reach at $14.45 during previous trading session. A total of 978054 shares exchanged hands, whereas the company’s average trading volume stands at 971.73 Million shares. Amag Pharmaceuticals (NASDAQ:AMAG) has a market capitalization of $515.43 Million and most recently 35.67 Million outstanding shares have been calculated.

According to sentiments of 10 analysts the mean estimates of short term price target for the company’s stock is marked at $17.8. The most optimistic analyst sees the stock reaching $22 while the most conventional predicts the target price at $12.

In terms of Buy/Sell recommendations, 10 analysts have a consensus rating of 2.5 on the shares of Amag Pharmaceuticals (NASDAQ:AMAG). Out of rating recommendations 1 have given the stock a Buy while 1 recommend the stock as Outperform. 8 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Amag Pharmaceuticals (NASDAQ:AMAG)’s distance from 20 day simple moving average is -0.0422 along with distance from 50 day simple moving average of 16.53 whereas its distance from 200 day simple moving average is 18.13. Amag Pharmaceuticals (NASDAQ:AMAG)’s price distance from 52-week high is -60.76 and from 52-week low is 21.17. The stock hit its 52-week high price on 12/15/16, and 52-week low price on 11/02/17. The stock’s 52-week price fluctuated within the range of $36.83 – $11.93.

Amag Pharmaceuticals (NASDAQ:AMAG)’s shares climbed 7.04% in the past week and plunged -13.47% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -28.82% while its year to date performance is at -58.48%.

While taking a glance at financials, we can look at a number of key indicators. Amag Pharmaceuticals (NASDAQ:AMAG) has a Return on Assets (ROA) of -9.3. The company currently has a Return on Equity (ROE) of -23.7 and a Return on Investment (ROI) of 3.5. Average true range (ATR-14) of the company sets at 0.99, along with its weekly and monthly volatility of 6.68% and 6.95% respectively. Relative strength index (RSI-14) for Amag Pharmaceuticals (NASDAQ:AMAG) is at 41.92. Beta value of the stock stands at 0.87.

The company’s price to free cash flow for trailing twelve months is 3.67. Its quick ratio for most recent quarter is 1.5 along with current ratio for most recent quarter of 1.6. Total debt to equity ratio of Amag Pharmaceuticals (NASDAQ:AMAG) for most recent quarter is 0.94 whereas long term debt to equity ratio for most recent quarter is 0.94.

Shares of Tailored Brands Inc (NYSE:TLRD) plunged -1.28% or -0.2 to reach at $15.43 during previous trading session. Tailored Brands Inc (NYSE:TLRD) has a market capitalization of $763.94 Million and most recently 49.51 Million outstanding shares have been calculated. A total of 977978 shares exchanged hands, whereas the company’s average trading volume stands at 1.24 Million shares.

According to 3 analysts Tailored Brands Inc (NYSE:TLRD)’s price will reach at $14.33 during 52 weeks. Stock’s minimum price target estimates has been figured out at $13 while the maximum price target forecast is established at $16.

According to the recommendations from 4 analysts stock has mean rating of 2 on the shares of Tailored Brands Inc (NYSE:TLRD). Out of rating recommendations 0 have given the stock a Buy while 1 recommend the stock as Outperform. 2 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

Shares of Tailored Brands Inc (NYSE:TLRD) climbed 1.65% in the past week and soared 14.55% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 31.1% while its year to date performance is at -39.61%.

Tailored Brands Inc (NYSE:TLRD)’s 52-week price fluctuated within the range of $28.76 – $9.40. Its price distance from 52-week high is -46.35 and from 52-week low is 64.15. The stock hit its 52-week high price on 12/21/16, and 52-week low price on 06/22/17. Tailored Brands Inc (NYSE:TLRD)’s distance from 20 day simple moving average is0.0279 along with distance from 50 day simple moving average of 14.57 whereas its distance from 200 day simple moving average is 12.4.

Total debt to equity ratio of Tailored Brands Inc (NYSE:TLRD) for most recent quarter is 0 whereas long term debt to equity ratio for most recent quarter is 0. The company’s price to free cash flow for trailing twelve months is 4.51. Its quick ratio for most recent quarter is 0.6 along with current ratio for most recent quarter of 2.7.

Average true range (ATR-14) of the company sets at 0.67, along with its weekly and monthly volatility of 4.90% and 4.58% respectively. Relative strength index (RSI-14) for Tailored Brands Inc (NYSE:TLRD) is at 55.22. Beta value of the stock stands at 1.88. Tailored Brands Inc (NYSE:TLRD) has a Return on Assets (ROA) of 2.8. The company currently has a Return on Equity (ROE) of -67.9 and a Return on Investment (ROI) of 8.6.